Donald Huffman

Donald Huffman

Inga fler pågående positioner
79 år
Health Technology
Consumer Services
Finance

Profil

Donald D.
Huffman
served as Chief Financial Officer at Celtrix Pharmaceuticals, Inc. from 1981 to 2000.
Held Chief Financial Officer roles at Sanderling Management CO LLC (2004-2006), Guava Technologies, Inc. (2006-2008), Asante Solutions, Inc. (2008-2010), and WaferGen Bio-systems, Inc. (2010-2012).
Occupied Chief Executive Officer & Chief Financial Officer positions at WaferGen Bio-systems, Inc. from 2010 to 2012.
Served as Director at Aerami Therapeutics, Inc. (2013-2014), SteadyMed Therapeutics, Inc. (2015-2018), and Aerami Therapeutics Holdings, Inc. Also held External Director role at SteadyMed Ltd. (2015-2018).
Chief Executive Officer & Director at Amarantus Bioscience Holdings, Inc. from 2021 to 2025.
Held Chief Financial Officer roles at Merck & Co., Inc., Essential Therapeutics, Inc., Philips Image Guided Therapy Corp., and Genteric, Inc. Education includes undergraduate degree from The Pennsylvania State University and MBA from State University of New York at Buffalo.

Tidigare kända positioner av Donald Huffman

FöretagPositionSlut
AMARANTUS BIOSCIENCE HOLDINGS, INC. Verkställande Direktör 2025-10-01
STEADYMED LTD Direktör/Styrelseledamot 2018-08-30
Direktör/Styrelseledamot 2018-01-01
WAFERGEN BIO-SYSTEMS, INC. Finansdirektör/CFO 2012-03-26
ASANTE SOLUTIONS INC Finansdirektör/CFO 2010-09-01
Se detaljerna i Donald Huffmans erfarenhet

Donald Huffmans utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

32

Första gradens relationer

16

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag16

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Donald Huffman